ArticleBMC neurology2024

Correction: Real‑world experience with calcitonin gene‑related peptide‑targeted antibodies for migraine prevention: a retrospective observational cohort study at two Japanese headache centers.

Mamoru Shibata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.